RX Crossroads 3PL Llc Pharmaceutical Import Profile — United States (DGFT 2022–2026)

Name: RX Crossroads 3PL Llc Pharmaceutical Import Records from India — 5 Products, $7.5M FOB USD (DGFT 2022–2026)
Creator: TransData Nexus

Suresh Sormare

Explore

RX Crossroads 3PL Llc — Pharmaceutical Importer Profile (2026) | 5 Products, $7.5M Trade | TransData Nexus

RX Crossroads 3PL Llc

Pharmaceutical Importer · United States · Corticosteroids Focus · $7.5M Total Trade · DGFT Verified

RX Crossroads 3PL Llc is a pharmaceutical importer based in United States with a total trade value of $7.5M across 5 products in 4 therapeutic categories. Based on 210 verified import shipments from Indian Customs (DGFT) records, RX Crossroads 3PL Llc is the #1 buyer in 1 product including Mitomycin. RX Crossroads 3PL Llc sources from 6 verified Indian suppliers, with Somerset Therapeutics Limited accounting for 68.3% of imports.

RX Crossroads 3PL Llc — Import Portfolio & Supplier Network

RX Crossroads 3PL Llc import network — 5 products from Indian suppliers. Source: Indian Customs (DGFT).

Who Are the Verified Indian Suppliers to RX Crossroads 3PL Llc?

Customs-verified supplier relationships from Indian DGFT records

Supplier	Value	Shipments	Share
Somerset Therapeutics Limited	$26.0M	1,056	68.3%
Somerset Therapeutics Private Limited	$6.9M	314	18.2%
Wintac Limited	$3.7M	145	9.8%

What Formulations Does RX Crossroads 3PL Llc Import?

Formulation	Value	Ships
Latanoprost ophthalmic solution	$1.0M	53
Latanoprost ophthalmic solution	$763.7K	45
Olopatadine hcl ophthalmic solution	$681.7K	23
Brimonidine tartrate ophthalmic	$627.9K	36
Ropivacaine hcl injection 0.5% 5MG/ML	$486.2K	22
Cyanocobalamin injection USP, 1000 MCG	$469.4K	11
Cyanocobalamin injection USP, 1000 MCG	$464.7K	11
Dexamethasone sodium phosphate INJ 10MG	$450.0K	9
Tobramycin ophthalmic solution USP	$360.4K	15
Tobramycin ophthalmic solution USP	$352.6K	14
Succinylcholine chloride injection	$345.5K	14
Ropivacaine hcl injection 0.5% 5MG/ML	$344.5K	16
Dexamethasone sodium phosphate INJ	$344.4K	10
Tropicamide ophthalmic solution, USP	$325.5K	14
Dexamethasone sodium phosphate INJ	$299.2K	9

RX Crossroads 3PL Llc imports 930 distinct pharmaceutical formulations. Showing top 15 by value. For full formulation-level data, contact TransData Nexus.

Import Portfolio — Top 5 by Import Value

#	Product	Category	Value	Ships	Share	Rk
1	Dexamethasone	Corticosteroids	$3.2M	64	1.8%	8
2	Tobramycin	Antibiotics	$2.0M	79	5.1%	5
3	Mitomycin	Advanced Oncology	$1.1M	21	12.9%	1
4	Sulfamethoxazole	Advanced Antibiotics	$636.0K	23	3.2%	6
5	Trimethoprim	Advanced Antibiotics	$636.0K	23	2.4%	6

RX Crossroads 3PL Llc imports 5 pharmaceutical products across 4 categories into United States totaling $7.5M. The company is the #1 buyer for 1 product: Mitomycin.

RX Crossroads 3PL Llc — Corporate Profile & Information

Company type, headquarters, distribution network, and industry role

1Company Overview

RX Crossroads 3PL LLC is a pharmaceutical importer and buyer based in the United States, specializing in the procurement of finished pharmaceutical formulations from international suppliers. Established in 2019, the company operates as a foreign limited liability company registered in Ohio. Its headquarters are located at 4200 Binion Way, Suite 200, Mason, Ohio 45036. The company is managed by Michele Lau, who serves as the Managing Member. RX Crossroads 3PL LLC plays a significant role in the United States pharmaceutical distribution network by sourcing a diverse range of pharmaceutical products from international markets, particularly India, to meet the demands of the U.S. healthcare sector.

2Distribution Network

RX Crossroads 3PL LLC maintains a centralized distribution facility at its headquarters in Mason, Ohio. The company employs a robust logistics infrastructure to manage the importation and distribution of pharmaceutical products across the United States. While specific details about additional warehouse locations are not publicly disclosed, the company's strategic position in Ohio facilitates efficient transportation and distribution to various regions within the U.S. The logistics capabilities include handling inbound shipments from international suppliers, managing inventory, and ensuring timely delivery to meet the needs of healthcare providers and pharmacies nationwide.

3Industry Role

RX Crossroads 3PL LLC functions primarily as a pharmaceutical importer and buyer within the United States. By sourcing finished pharmaceutical formulations from international suppliers, especially from India, the company acts as a critical intermediary in the pharmaceutical supply chain. This role involves ensuring a steady supply of essential medications to the U.S. market, thereby supporting the healthcare system's needs. The company's operations are integral to maintaining the diversity and availability of pharmaceutical products, contributing to the overall resilience and efficiency of the U.S. pharmaceutical distribution network.

TransData Nexus Research · Company registries, industry databasesMar 2026

Supplier Relationship Intelligence — RX Crossroads 3PL Llc

Sourcing concentration, supply chain resilience, and strategic implications

1Sourcing Concentration Analysis

RX Crossroads 3PL LLC exhibits a high degree of sourcing concentration, with a significant portion of its pharmaceutical imports originating from a select group of suppliers. Notably, Somerset Therapeutics Limited is the primary supplier, accounting for 68.3% of the total import value, followed by Somerset Therapeutics Private Limited at 18.2%, and Wintac Limited at 9.8%. This concentrated sourcing strategy may offer benefits such as streamlined logistics and potentially favorable pricing agreements. However, it also introduces risks associated with over-reliance on a limited number of suppliers, including potential supply disruptions due to geopolitical issues, regulatory changes, or operational challenges faced by these suppliers. The stability of the relationship with these suppliers is crucial for maintaining a consistent supply chain. The company's shipment data indicates a substantial number of transactions with these suppliers, suggesting established and ongoing partnerships. Nonetheless, the concentration of sourcing warrants strategic consideration to mitigate potential risks associated with supplier dependency.

2Supply Chain Resilience

The resilience of RX Crossroads 3PL LLC's supply chain is closely tied to the stability and reliability of its primary suppliers in India. The company's significant reliance on Somerset Therapeutics Limited, Somerset Therapeutics Private Limited, and Wintac Limited underscores the importance of these suppliers in maintaining a consistent supply of pharmaceutical products. While the company has established relationships with these suppliers, the lack of publicly available information regarding backup suppliers or alternative sourcing strategies suggests a potential vulnerability in the supply chain. The diversity of formulations imported, with 930 unique formulations, indicates a broad product range; however, the concentration of sourcing from a few suppliers may limit flexibility in responding to supply chain disruptions. Additionally, the exposure to shipping routes from India introduces potential risks related to geopolitical factors, natural disasters, or logistical challenges. Ensuring that key suppliers adhere to international regulatory standards, such as those set by the World Health Organization (WHO) and the Central Drugs Standard Control Organisation (CDSCO) in India, is essential for maintaining product quality and compliance. The company's supply chain resilience would benefit from diversifying its supplier base and establishing contingency plans to mitigate potential disruptions.

Importing Pharmaceuticals into United States — Regulatory Framework

Regulatory authority, GMP requirements, import licensing for United States

1Regulatory Authority & Framework

In the United States, the Food and Drug Administration (FDA) serves as the primary regulatory authority overseeing the importation, distribution, and marketing of pharmaceutical products. The FDA enforces regulations to ensure that imported drugs meet safety, efficacy, and quality standards before they enter the U.S. market. Key legislation governing pharmaceutical imports includes the Federal Food, Drug, and Cosmetic Act (FDCA), which outlines the requirements for drug approval, labeling, and manufacturing practices. The Drug Enforcement Administration (DEA) also plays a role in regulating controlled substances, ensuring that imports comply with the Controlled Substances Act. For Indian generics to be marketed in the U.S., they must undergo the FDA's Abbreviated New Drug Application (ANDA) process, demonstrating bioequivalence to the brand-name counterpart. This pathway ensures that generic drugs are therapeutically equivalent and meet the FDA's standards for safety and efficacy.

2Import Licensing & GMP

Import licensing requirements for pharmaceutical products entering the United States are stringent. Importers must register with the FDA and obtain an Importer of Record (IOR) number. Each drug product must be accompanied by a valid FDA registration number, and the manufacturing facility must be registered with the FDA. Good Manufacturing Practice (GMP) certification is mandatory for foreign manufacturers. The FDA recognizes GMP certifications from various international standards, including the European Union (EU) GMP, World Health Organization (WHO) GMP, and the Pharmaceutical Inspection Co-operation Scheme (PIC/S). These certifications ensure that manufacturing processes meet international quality standards. Additionally, importers must comply with the FDA's wholesale distribution authorization requirements, which include maintaining proper records, ensuring product traceability, and adhering to storage and handling guidelines to prevent contamination or degradation of pharmaceutical products.

RX Crossroads 3PL Llc — Procurement Pattern Analysis

Product strategy, sourcing profile, and market positioning

1Product Strategy

RX Crossroads 3PL LLC's focus on importing specific therapeutic categories—corticosteroids, antibiotics, and advanced antibiotics—aligns with the ongoing demand for these medications in the U.S. healthcare system. Corticosteroids are widely used for their anti-inflammatory properties, antibiotics are essential for treating bacterial infections, and advanced antibiotics are critical in combating resistant strains. The company's import strategy is likely driven by market needs, aiming to provide a consistent supply of these vital medications to healthcare providers and pharmacies. By concentrating on these therapeutic areas, RX Crossroads 3PL LLC can leverage its expertise and supplier relationships to meet the specific demands of the U.S. market, ensuring that patients have access to necessary treatments.

2Sourcing Profile

RX Crossroads 3PL LLC's sourcing strategy emphasizes the procurement of generic pharmaceutical drugs, particularly from India, which is known for its robust generic drug manufacturing industry. The company's preference for finished pharmaceutical formulations indicates a focus on ready-to-market products that meet the FDA's standards for safety, efficacy, and quality. India's compliance with international GMP standards, such as those recognized by the WHO and PIC

TransData Nexus Research · DGFT trade data analysis

Frequently Asked Questions — RX Crossroads 3PL Llc

What products does RX Crossroads 3PL Llc import from India?

RX Crossroads 3PL Llc imports 5 pharmaceutical products across 4 categories. Top imports: Dexamethasone ($3.2M), Tobramycin ($2.0M), Mitomycin ($1.1M), Sulfamethoxazole ($636.0K), Trimethoprim ($636.0K).

Who supplies pharmaceuticals to RX Crossroads 3PL Llc from India?

RX Crossroads 3PL Llc sources from 6 verified Indian suppliers. The primary supplier is Somerset Therapeutics Limited (68.3% of imports, $26.0M).

What is RX Crossroads 3PL Llc's total pharmaceutical import value?

RX Crossroads 3PL Llc's total pharmaceutical import value from India is $7.5M, based on 210 verified shipments in Indian Customs (DGFT) data.

What therapeutic categories does RX Crossroads 3PL Llc focus on?

RX Crossroads 3PL Llc imports across 4 categories. The largest: Corticosteroids (42.5%), Antibiotics (26.6%), Advanced Antibiotics (16.9%).

Get Full RX Crossroads 3PL Llc Import Intelligence

Access shipment-level details, supplier connections, pricing data, and competitive analysis. TransData Nexus provides verified Indian Customs (DGFT) data trusted by pharmaceutical trade professionals worldwide.

Contact for Data Access Request Live Demo

Official References & Regulatory Resources

Verify import regulations and drug registration requirements with the agencies above.

Research Methodology & Data Transparency

Suresh Sormare

Verified Author

Pharmaceutical Export-Import Analyst & Trade Intelligence Expert

Suresh Sormare is a pharmaceutical export-import analyst with deep expertise in Indian Customs (DGFT) data, HS code classification, and global pharmaceutical supply chains. His analysis covers 10M+ shipment records across 150+ countries and is used by manufacturers, procurement agencies, and trade consultants worldwide. Suresh specializes in identifying verified suppliers and buyers from customs records, mapping bilateral pharmaceutical trade corridors, analyzing tariff structures and regulatory frameworks across 170+ destination markets, and benchmarking competitive positioning for finished pharmaceutical formulations. His methodology combines granular customs transaction data with regulatory intelligence from FDA, EMA, WHO, CDSCO, and 40+ national drug authorities to deliver actionable trade insights for the pharmaceutical formulations sector.

linkedin.com/in/sureshsormare

Primary Data Source

All trade data is sourced from Indian Customs (DGFT) official shipping bill records — the authoritative government database for India's pharmaceutical trade. Each verified record contains exporter name, consignee (buyer) name, detailed product description, quantity, declared FOB value (USD), port of loading, destination country, and shipment date.

Data Source & Methodology

Trade data sourced from Indian Customs (DGFT) export shipment records. Values represent FOB export value in USD. For current shipment-level data, contact TransData Nexus.